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Abstract
We report a case of persistent left superior vena cava (PLSVC) incidentally
recognized during the implantation of a cardioverter-defibrillator. PLSVC is the
most common venous anomaly of the thorax and drains into the right atrium.
There are a lot of publications reporting success of pacemaker or defibrillator
lead implantations via PLSVC. In this article we present the technique of
approaching the right ventricle and right atrium via PLSVC; sometimes this
method can be as straightforward as the classical way. Therefore, if PLSVC is
recognized intra-operatively, we suggest continuing left-sided implantation, and
considering a right venous access only in case of failure.
K Ke ey y   w wo or rd ds s: :   implantable cardiac-defibrillator, persistent left superior vena cava,
defibrillator lead implantation.
Introduction
Persistent left superior vena cava (PLSVC) is a benign congenital
vascular  anomaly  affecting  0.3-2%  of  healthy  subjects  [1].  The
most common variation in this anomaly comprises 90% of all PLSVC
reports presenting with both right and left superior vena cava. The PLSVC
drains into the right atrium directly or most often through a dilated
coronary sinus [1]. Isolated PLSVC is usually not recognized until the left
cephalic or subclavian approach is used for diagnostic or therapeutic
transcatheter procedures. Transvenous introduction of the lead from the
right atrium to the right ventricle through the PLSVC may become
a technically difficult procedure. It is often very time consuming and
requires lengthy X-ray exposure. This paper is a case report of successful
cardiac-defibrillator (ICD) implantation via the PLSVC. 
Case report 
A 39-year-old male with cardiomyopathy and left ventricle ejection
fraction (LVEF) 20% in functional status NYHA class II with a history of
ventricular tachycardia and paroxysmal atrial fibrillation was referred to
our  department  for  cardioverter-defibrillator  implantation.  Before
implantation,  nuclear  magnetic  resonance  (NMR)  examination  was
performed. On the basis of NMR, the diagnosis of dilated cardiomyopathy
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after myocarditis was established. This examination
showed severe left ventricular dilation (80/69 mm)
and dysfunction – LVEF was 15-20% with global
hypokinesis. Examination of blood flow to the heart
was not performed because no congenital thoracic-
abdominal abnormalities were considered. 
During ICD implantation, puncture of the left
subclavian vein revealed PLSVC. Venography showed
that this vein drains into the right atrium through
a dilated coronary sinus (Figure 1). The typical ICD 
1-coil  active  lead  6935  (Medtronic,  Tolochenaz,
Switzerland) was used and introduced into the right
atrium,  then  a U-shape  stylet  was  formed  and
through a wide loop within the right atrium the lead
was easily introduced and fixed to the high septum
of the right ventricle. Measurements confirmed good
electrical para  meters: R-wave was 14.0 mV and
stimulating threshold was 0.6 V/0.5 ms. Through the
next puncture of the left subclavian vein and PLSVC
the atrial active fixation lead Optisense 1699TC (St.
Jude Medical, St. Paul, MN, USA) was introduced and
screwed in the high lateral wall of the right atrium. In
this position, the electrical parameters were also
acceptable: P-wave was 1.6 mV, and atrial stimulating
threshold was 0.5 V/0.5 ms. Finally a dual chamber
ICD Medtronic Maximo DR (Medtronic, Tolochenaz,
Switzerland) was im  plan  ted in the left pectoral region.
The total procedure time was similar to that of the
classical ICD implantation – 1 hour and 30 min.
Fluoroscopy  time  was  also  brief  –  5  min.  No
complications  were  encountered  during  the
procedure.
Electrical parameters were controlled 24 hours
a day for the duration of 7 days after implantation
and were comparable to those during the operation.
A chest X-ray also confirmed the stable location of
leads.  The  defibrillation  threshold  test  was
performed  7  days  after  implantation.  Induced
ventricular fibrillation was successfully recognized
and terminated by 20 J shock. Because the right
ventricular lead is located in an atypical position
(Figures 2, 3) – the coil goes across the tricuspid
valve and the lead tip is fixed close to the tricuspid
annulus – we recommended frequent follow-up
visits. The next follow-up visit is planned for one
month after implantation. 
F Fi ig gu ur re e    2 2. .    Antero-posterior  (AP)  view.  Screw-in
ventricular defibrillator electrode is positioned on
the high septum of the right ventricle. Atrial lead is
screwed in the high lateral wall of the right atrium
F Fi ig gu ur re e   3 3. . Right ventricular defibrillation lead and atrial
lead location. Right anterior oblique (RAO) 30° view 
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F Fi ig gu ur re e   1 1. .   Venography demonstrating persistent left
superior vena cava (PLSVC) drains into the right
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Discussion
There are a lot of publications about successful
pacemaker or defibrillator lead implantations via
PLSVC [2-8]. The major obstacle for this procedure
is right ventricular lead implantation due to the tip
of the lead deflecting away from the tricuspid
annulus. Approaches to overcome this issue include:
manual reshaping of the stylet into a U-shaped
stylet, necessitating considerable manoeuvring,
forming a loop in the right atrium using the right
atrial  free  wall  for  support,  ventricular  lead
placement in the left ventricular branch of the
coronary sinus and use of an atrial “J” stylet for
ventricular lead placement [2]. Konstantino et al.
reported a technique of ICD lead implantation via
PLSVC using a coronary sinus delivery system as
used today in cardiac resynchronization therapy [9].
The majority of authors presented implantation via
PLSVC as technically difficult, time consuming and
requiring  prolonged  fluoroscopy.  Biffi  et  al.
compared patients implanted through LSVC and
classically; the fluoroscopy time was similar to right
sided  implants  (480  ±18  s  vs.  460  ±127  s, 
P = NS) but procedure time was longer (195 ±7 vs.
120 ±29 min, P < 0.03) [2]. In the manuscript
presented by Ratliff et al. the fluoroscopy time
varies from 5 to 20 min and procedure time from
70 to 225 min [1]. In our case we showed that
anatomical conditions of some patients with PLSVC
are not always a substantial obstacle for successful
implantation considering also the similar X-ray
exposure and procedure time as that of the classical
approach. Therefore we suggest that implantation
via PLSVC should be performed in any case when
diagnosis is made intraoperatively unless catheter
handling appears difficult or fluoroscopy time
exceeds a defined time by the operator. Left-side
implantation ICDs may have a lower defibrillation
threshold compared to right-sided placement [10].
Current  ICD  generations  are  also  capable  of
achieving acceptable defibrillation thresholds when
placed in the right pectoral. 
We  conclude  that  in  the  era  of  increasing
procedures with device implantation operators
should be aware of the possibility of PLSVC. After
the left subclavian vein is punctured the guide wire
takes an unusual left-sided downward course,
crossing to the coronary sinus or directly to the right
atrium. Not every case introduces and manipulates
the  lead  complex.  PLSVC  in  general  does  not
prevent successful placement of an active fixation
ICD lead and left-side device implantation. If PLSVC
is  recognized  intra-operatively  we  suggest
continuing the transvenous left-sided approach and
considering a right venous access in case of failure
to reach a convenient site. 
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